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Abstract
Borna disease virus (BDV) is a nonsegmented, negative-strand RNA virus that employs several unique strategies for gene
expression. The shortest transcript of BDV, X/P mRNA, encodes at least three open reading frames (ORFs): upstream
ORF (uORF), X, and P in the 59 to 39 direction. The X is a negative regulator of viral polymerase activity, while the P
phosphoprotein is a necessary cofactor of the polymerase complex, suggesting that the translation of X is controlled
rigorously, depending on viral replication. However, the translation mechanism used by the X/P polycistronic mRNA has not
been determined in detail. Here we demonstrate that the X/P mRNA autogenously regulates the translation of X via
interaction with host factors. Transient transfection of cDNA clones corresponding to the X/P mRNA revealed that the X ORF
is translated predominantly by uORF-termination-coupled reinitiation, the efficiency of which is upregulated by expression
of P. We found that P may enhance ribosomal reinitiation at the X ORF by inhibition of the interaction of the DEAD-box RNA
helicase DDX21 with the 59 untranslated region of X/P mRNA, via interference with its phosphorylation. Our results not only
demonstrate a unique translational control of viral regulatory protein, but also elucidate a previously unknown mechanism
of regulation of polycistronic mRNA translation using RNA helicases.
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Introduction
The control of translation initiation on mRNA is one of the
most fundamental processes in the regulation of gene expression.
Most eukaryotic mRNAs initiate translation via the so-called
‘‘scanning mechanism’’, in which the 40S ribosomal subunit binds
to the cap structure at the 59-terminus of mRNA and slides to the
proximal AUG codon [1]. In this mechanism, translation initiation
from the downstream AUGs is generally inefficient. Thus, the
eukaryotic cellular genes are transcribed individually, generating
monocistronic mRNAs. On the other hand, many animal viruses
produce polycistronic mRNAs and express efficiently functionally
different proteins from a single mRNA molecule [2–5], suggesting
that eukaryotic ribosomes have the potential to initiate the
translation of downstream ORFs, under the control of sequence-
and/or structure-dependent features of the mRNAs.
Polycistronic coding by mRNAs is a means of coordinating the
expression of more than two proteins, which are arranged in
tandem or overlapping in a single mRNA molecule [6,7]. Analysis
of polycistronic mRNAs therefore provides a better understanding
of the regulatory mechanisms of ribosomal scanning during
mRNA translation. In the leaky scanning mechanism, ribosomes
bypass the first start codon when the context is poor and thus
reach a start codon further downstream. Some viruses, such as
Sendai virus and papillomaviruses, use such mechanisms to enable
a multifunctional mRNA to express several proteins with different
functions in viral replication [8–10]. Another strategy for
translation of downstream cistrons from an mRNA is termina-
tion/reinitiation, is the major method of translation of prokaryotic
and some viral mRNAs [11–13]. In this case, ribosomes resume
the scanning of the mRNA and reinitiate translation efficiently at a
downstream AUG codon, following the termination of an
upstream cistron. Although eukaryotic ribosomes are in general
unable to reinitiate downstream cistrons on an mRNA, it is also
true that about 10 to 30% of eukaryotic mRNAs contain upstream
AUG codons (uAUG), which have the capacity to initiate
translation of a short upstream ORF (uORF), usually consisting
of fewer than 30 codons [14–16]. The uORF-mediated reinitiation
of downstream ORFs also has been demonstrated in eukaryotic
mRNAs [17–20], suggesting that ribosomal termination/reinitia-
tion may be a key mechanism for the regulation of complex gene
expression in eukaryotic cells. However, we know little about the
molecular mechanisms underlying the regulation of ribosomal
initiation in the translation of polycistronic mRNA, especially how
eukaryotic viruses use translational regulation in the expression of
viral proteins.
PLoS Pathogens | www.plospathogens.org 1 November 2009 | Volume 5 | Issue 11 | e1000654Borna disease virus (BDV) is a non-segmented, negative-sense
RNA virus that belongs to the Mononegavirales and which is
characterized by highly neurotropic and persistent infection. BDV
replicates and is transcribed in the cell nucleus and employs several
unique strategies for gene expression [21,22]. One of the most
striking characteristics of this virus is that all of the BDV transcripts
have polycistronic coding capacity. The shortest, 0.8 kb transcript
of BDV, X/P mRNA, encodes at least three ORFs: uORF, X, and
P in the 59 to 39 direction (Figure 1A). The X and P ORFs produce
major viral proteins, which overlap by 215 nucleotides (nt) [23,24].
In contrast, the uORF, whose stop codon overlaps the X translation
start codon (X-AUG) by one nt, UGAUG, (Figure 2A), encodes an
8 amino acid peptide, the expression of which has not yet been
shown in infected cells. BDV X is a negative regulator of viral
polymerase activity, while the P phosphoprotein is a necessary
cofactor of the polymerase complex [25,26]. Thus, the expression
ratio between X and P is critical for viral polymerase activity
[25–28]. Previousstudies revealed that, despite an optimal sequence
context for initiation of X compared to P, translation of X seems to
be suppressed at an early stage of viral infection and gradually
increases along with the establishment of persistent infection (Figure
S1) [29,30]. This finding allows us to hypothesize that translational
regulation of such a short polycistronic mRNA may have evolved to
control rigorously the ratio between X and P in the infected cell
nucleus and is essential for the maintenance of the persistent
infection. Recent studies have suggested that the 59 untranslated
region (59 UTR) of X/P mRNA plays a critical role in the
translational regulation of X from the polycistronic mRNA [28,31].
However, the translation mechanism used by the X/P polycistronic
mRNA has not been determined in detail.
In this study, we demonstrate the autogenous translational
regulation of the X/P polycistronic mRNA mediated by host RNA
helicases. We show that DDX21, also known as RNA helicase II/Gu,
is a regulator of ribosomal reinitiation of X via interaction with the 59
UTR of X/P mRNA (X/P UTR) and that expression of the
downstream P protein may regulate the translation of X by interfering
with the binding of DDX21 to the 59 UTR. Our results provide not
only a unique insight into translational control of a viral polycistronic
mRNA but also a novel role for RNA helicase in the regulation of
ribosomal reinitiation during eukaryotic mRNA translation.
Results
Translational regulation of BDV X from the X/P
polycistronic mRNA
To investigate translational regulation of the X/P polycistronic
mRNA, we first used a plasmid, pX/Pwt [30], which encodes a
Author Summary
All viruses rely on host cell factors to complete their life
cycles. Therefore, the replication strategies of viruses may
provide not only the understanding of virus pathogenesis
but also useful models to disentangle the complex
machinery of host cells. Translation regulation of viral
mRNA is a good example of this. Borna disease virus (BDV)
is a highly neurotropic RNA virus which is characterized by
persistent infection. BDV expresses mRNAs as polycistronic
coding transcripts. Among them, the 0.8 kb X/P mRNA
encodes at least three open reading frames (ORFs),
upstream ORF, X, and P. Although BDV X and P have
opposing effects in terms of viral polymerase activity, the
translational regulation of X/P polycistronic mRNA has not
been elucidated. In this study, we show an ingenious
strategy of translational control of viral regulatory protein
using host factors. We demonstrate that host RNA
helicases, mainly DDX21, can affect ribosomal reinitiation
of X via interaction with the 59 untranslated region (UTR) of
X/P mRNA and that the downstream P protein autoge-
nously controls the translation of X by interfering with the
binding of DDX21 to the 59 UTR. Our findings uncover not
only a unique translational control of viral regulatory
protein but also a previously unknown mechanism of
translational regulation of polycistronic mRNA using RNA
helicases.
Figure 1. Autogenous regulation of BDV X translation from the X/P polycistronic mRNA. (A) A schematic representation of the 0.8 kb BDV
polycistronic X/P mRNA. The numbers indicate nucleotide positions in the X/P mRNA. (B) COS-7 cells andOL cells were transfected with pX/Pwt, and the
total cell lysates were used for Western blotting probed with anti-BDV P andX antibodies at 24 and 48 h post-transfection. The expression ratio of X to P
was determined after quantitation of band intensities by ImageJ software. (C) OL cells were transfected with pX/Pwt (0.5 mg) and the subcellular
localization of X and P was determined by immunofluorescence assay. Arrows indicate cytoplasmic localization of X and P at 72 h post-transfection.
doi:10.1371/journal.ppat.1000654.g001
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whether this plasmid is able to reproduce the translational
regulation of X/P mRNA independently of BDV infection. Upon
transfection into COS-7 and OL cells, the plasmid produced
efficiently both X and P, and expression of X appeared to increase
following the course of time after transfection (Figure 1B), similar
to the expression dynamics of X in BDV-infected cells (Figure S1)
[30,32]. Previous studies revealed that P translocates to the
cytoplasm from the nucleus via interaction with X [28,30,33]. As
shown in Figure 1C, although the cells transfected with pX/Pwt
exhibited the nuclear distribution of P at an early time after
transfection, P was shown to move to the cytoplasm of the cells
expressing X at 72 h post-transfection (arrows). These observa-
tions suggested that the X/P mRNA by itself regulates the
translation of X independently of BDV infection and, therefore,
that pX/Pwt provides a useful tool to investigate the translational
regulation of the polycistronic mRNA.
The uORF controls translation initiation of the X and P
ORFs
To understand the role of the uORF in the translation of the X
and P ORFs, we generated a series of mutant plasmids (Figure 2A)
and examined the expression of X and P by Western blotting at
12 h post-transfection, at which point the expression of X had not
yet been upregulated. Mutants with the uAUG replaced by TAG
or TTG exhibited markedly increased expression of X compared
to the wt plasmid (Figure 2B and 2C, lanes 1 and 2). In addition,
the involvement of uORF in the translation of X was
demonstrated by using a series of deletion mutants of the 59
UTR (Figure S2). In contrast, the translation of P was reduced to
approximately 50% of the wt plasmid (lanes 1 and 2). In addition,
changing the initiation codon of X (X-AUG) to TTG in the above
uAUG mutants recovered the expression level of P to the
equivalent of the wt plasmid (lanes 3 and 4). Furthermore, single
mutants, which lack only the X ORF, with substitution of the
X-AUG by AGC or ACG produced P at levels comparable to the
wt plasmid with complete abolition of the expression of X (lanes 5
and 6). These observations suggested that the uAUG is recognized
efficiently by scanning ribosomes and that the presence of the
uORF seems to downregulate the basal expression level of X,
while enhancing the translation efficiency of the P ORF to a level
equivalent to an mRNA lacking both the uORF and X ORF.
To determine how translation of the X and P ORFs is initiated
from the X/P mRNA, we next introduced mutations into the
termination codon of the uORF. A mutant in which the uORF
stop codon had been changed to TTA expressed both X and P at
equivalent levels to the wt plasmid (lane 7). Furthermore, a 3-nt
downstream extension of the uORF termination codon also
appeared not to influence the translation of either protein (lane 8).
Meanwhile, downstream extension of the uORF to 29 nt reduced
the expression of X, but not P, to 70% of the wt level (lane 9).
Interestingly, a 164 nt extension of the uORF, so that a stop codon
is introduced within the P ORF, showed significant decreases
(,30%) in the expression of both X and P (lane 10). The
introduction of premature stop codons within the uORF also
reduced the expression level of X (Figure S3). These results
Figure 2. The uORF influences translation of the X and P ORFs. (A) Schematic representation of mutants of the X/P expression plasmid. The
nucleotide sequences substituted in the wt plasmid are indicated. (B) OL cells were transfected with 0.8 mg of each plasmid and at 12 h after
transfection cells were harvested and subjected to Western blotting using anti-BDV P and X antibodies. (C) Fold-activation of X and P expression in
the cells transfected with mutant plasmids was determined after quantitation of band intensities by ImageJ software. The mean plus S.D. of three
independent experiments are shown. **P,0.01, *P,0.05 (Student’s t test).
doi:10.1371/journal.ppat.1000654.g002
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close proximity to the X-AUG seems to be important for efficient
translation of the X ORF. Furthermore, termination of the uORF
before initiation of the P ORF is required for the expression of P.
We also demonstrated that P is unlikely to be expressed by
ribosomal shunting or internal ribosome entry site-mediated
mechanism (Figure S4). Taken together, both the X and P ORFs
were shown to be translated predominantly by ribosomal
reinitiation, dependent on uORF termination, and the remainder
of the translation (approximately 30%) might be initiated by leaky
scanning of upstream start codons.
Translation initiation of the X ORF is upregulated by P
The results shown above suggest that uORF-termination/
reinitiation may play a key role in the regulation of translation of
X. Therefore, we sought next to investigate the factors that
influence ribosomal reinitiation at the X ORF. At first, we
examined the role of the peptide predicted to be produced by the
uORF. However, we could not detect any effects of this predicted
peptide on the translation of the downstream ORFs (Figure S5).
We next examined the effect of the protein encoded
downstream, P, because this may accumulate in the nucleus in
association with the expression of the X/P mRNA [34]. We
generated mutant plasmids, pX/PDP, in which the initiation
codon of P, P-AUG, was substituted by TTG, and puORF-X/
PDP, in which the uORF was fused in-frame to the X ORF in
pX/PDP, and assessed the production of X at 48 h post-
transfection, at which point P should have accumulated sufficiently
in wt plasmid-transfected cells. As shown in Figure 3A, translation
of X was significantly higher in cells transfected with pX/Pwt than
Figure 3. Expression of BDV P enhances translation of the X ORF. (A) OL cells were transfected with 0.8 mg of the plasmids indicated and,
48 h after transfection, expression of the X and uORF-X fusion proteins was detected by Western blotting using anti-BDV P and X antibodies. The
asterisk in the puORF-X/P-transfected panel indicates a non-specific reaction. (B) OL cells were cotransfected with pX/PDP or puORF-X/PDP (0.4 mg)
and a four-fold dilution series of BDV N (pcN) or P (pcP) expression plasmid (0.00625, 0.025, 0.1 and 0.4 mg). The empty plasmid was used for
equilibration of the total amount of transfected plasmid. The cells were harvested at 48 h post-transfection and subjected to Western blotting. The
expression of BDV N was detected by anti-BDV N monoclonal antibody. (C) OL cells were transfected with 0.8 mg of the plasmids indicated in the
presence or absence of P and, 48 h after transfection, expression of the P and X was detected by Western blotting using anti-BDV P and X antibodies.
Relative expression levels of detected proteins were determined after quantitation of band intensities by ImageJ software. The mean plus S.D. of
three independent experiments are shown. **P,0.01, *P,0.05 (Student’s t test).
doi:10.1371/journal.ppat.1000654.g003
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fusion protein appeared not to be affected by deletion of the P-
AUG. These results indicated that expression of P upregulates the
translation of the X ORF without affecting the ribosomal initiation
from the uAUG. To verify this, a plasmid expressing P, pcP [33],
was cotransfected with pX/PDP or puORF-X/PDP. Interestingly,
expression of X, but not the uORF-X fusion protein, was
enhanced markedly in a dose-dependent manner by co-expression
of P, while the nucleoprotein (N) of BDV failed to enhance the
expression of X in transfected cells (Figure 3B). A DP mutant based
on a 164-bp uORF-extension plasmid (Figure 2A, lane 10),
puORF164DP, also upregulated the expression of X in the
presence of P (Figure 3C), although the basal expression level of X
in the puORF164DP is significantly lower than that in pX/PDP
both with or without P. These data suggested that P influences the
ribosomal initiation at the X-AUG predominantly by the uORF-
termination-coupled reinitiation mechanism, while a leaky scan-
ning mechanism may be involved to some extent in the
upregulation of the translation of X by P.
Nuclear factor(s) inhibit translation of the X ORF by
binding to the 59 UTR
We set out to address next the question of how the expression of
P can enhance the reinitiation of translation of X. First, we
investigated the possibility that P may interact directly with the X/
P mRNA and then influence ribosomal reinitiation at the X ORF.
We could not demonstrate, however, a direct interaction between
P and the X/P mRNA by immunoprecipitation (IP)-RT-PCR
analysis (data not shown). Second, it might be possible that P
affects the functions of eukaryotic initiation factors (eIFs), such as
eIF2a and eIF3. However, an interaction between eIFs and BDV
P was not demonstrable in cells transfected with BDV P (Figure
S6A). Furthermore, expression of eIF2a,2 B e and 3A, as well as
the serine phosphorylation level of eIF2a, appeared not to be
changed in cells expressing P (Figure S6B), indicating that the
expression of P is unlikely to affect the quantitative and qualitative
properties of eIFs.
We therefore considered the possibility that P enhances the
translation of X indirectly by interaction with cellular factor(s),
which may affect ribosomal reinitiation at the X ORF. To
investigate this, we conducted first an in vitro translation assay using
in vitro transcribed X/P mRNAs encoding firefly luciferase fused
with the X ORF and cellular extracts of OL cells. As shown in
Figure 4A, luciferase activity was markedly reduced in the
presence of the nuclear extract, but not the cytoplasmic extract,
demonstrating that the nucleus may contain factor(s) that suppress
translation initiation from the X-AUG. Interestingly, a mutant X/
P RNA, which lacks a 38-mer from the 59 end of the UTR,
retained luciferase activity even in the presence of the nuclear
extract (Figure 4A), suggesting that nuclear factors may influence
the translation of X via interaction with the 59 UTR. To verify
this, we used 48-mer decoy RNAs, which represent the X/P UTR
and, as a control, the 59 UTR of another BDV polycistronic
mRNA (M/G UTR). As shown in Figure 4B, incubation with the
X/P UTR decoy RNA, but not the M/G UTR control, interfered
with the inhibitory effect of the nuclear extract in a dose-
dependent manner. We also performed an RNA-electrophoretic
mobility shift assay (RNA-EMSA) using
32P-labeled riboprobes
corresponding to the X/P UTR and M/G UTR to determine
whether the nuclear extract interacts specifically with the X/P
UTR. As shown in Figure 4C, we found that the X/P UTR
riboprobe forms complexes with the nuclear extract (arrows) and
that an excess of cold riboprobe efficiently interferes with complex
formation. On the other hand, the M/G UTR probe failed not
only to generate clear complexes with the extract (Figure 4C) but
also to interfere with the complex formation of X/P UTR probe
(Figure 4D). All these observations suggested the presence of
nuclear factors that inhibit the translation of the X ORF via
interaction with the 59 UTR of X/P mRNA.
Identification of the 59 UTR-binding proteins of X/P
mRNA
To investigate in more detail the involvement of nuclear factors
in the translational regulation of X, we tried to identify the nuclear
factors using a stepwise purification assay and RNA-affinity
columns coupled with short (20 mer) and full-length (48 mer)
X/P UTR RNAs (see Materials and Methods). The nonspecific
RNA binding was visualized using an RNA-affinity column
coupled with M/G UTR control RNA. As shown in Figure 5A,
seven specific bands were detected by SDS-PAGE. The bands
were excised and digested with trypsin and analyzed further by
LC-MS/MS. We found that these bands represent DDX21,
DDX50, DNA topoisomerase 1 (TOP1), hnRNPQ1/2 and
nucleolin (Figure 5A). The accuracy of this analysis was confirmed
by Western blotting with antibodies specific for each protein
(Figure 5B).
Among the X/P UTR-binding proteins (UBPs), direct interac-
tion has been demonstrated only between nucleolin and TOP1
[35]. Coimmunoprecipitation experiments using Flag-tagged
UBPs revealed interactions among DDX21, nucleolin, and
TOP1 (Figure 6A and 6B). In addition, interactions of DDX50
and hnRNPQ1 with nucleolin and DDX21, respectively, were
demonstrated when hemagglutinin (HA)-tagged proteins were
expressed as targets (Figure 6C and 6D). Furthermore, we
demonstrated that nucleolin interacts with DDX21 through its
C-terminal region using a pull-down analysis with GST- and His-
fused recombinant proteins (Figure S7). These observations
indicated that the UBPs interact with each other and may have
been isolated from the affinity columns as complexes.
To determine which UBPs contribute dominantly in binding to
the X/P UTR, we performed IP-RT-PCR analysis using BDV-
infected OL cells and X/P mRNA-specific primers. As shown in
Figure 7A, X/P mRNA was amplified clearly from the cells
transfected with Flag-tagged DDX21 and nucleolin. Furthermore,
RNA EMSA using GST-fused DDX21 and nucleolin revealed
that DDX21 interacts directly only with the X/P UTR (Figure 7B),
while nucleolin binds to both the X/P UTR and the control M/G
UTR (arrowhead). We also found by competitive EMSA that
DDX21 binds more strongly to the X/P UTR than nucleolin (data
not shown). Nucleolin binds a wide variety of DNA/RNA
molecules and is known usually to work in concert with other
proteins, which may provide the functional specificity [36,37].
Along with these properties of nucleolin, our results strongly
suggested that DDX21 is a core protein that interacts with the
X/P UTR.
DDX21 causes structural alteration of the X/P UTR
DDX21 is known to have RNA helicase activity, which may link
to RNA-folding and/or -unwinding through its binding directly to
target RNA elements [38]. These observations led us to
hypothesize that the interaction of DDX21, along with other
UBPs, causes a structural change of the X/P UTR, impacting on
ribosomal reinitiation at the X ORF. To determine whether
DDX21 alters the structure of the 59 UTR, therefore, we
performed an in vitro RNA folding assay using a
32P-labeled X/P
UTR probe. At first, we monitored the mobility of the X/P UTR
riboprobe in a 12% native PAGE with or without boiling. As
shown in Figure 8A and 8B, the probe produced low mobility
Translational Control of a BDV Polycistronic mRNA
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to major bands (arrowheads), which are also seen in the gel
without boiling (lane 1). The intensities of these low mobility bands
were relatively stable during the equilibration period after the
quick-cooling step (data not shown), indicating that the low
mobility bands represent the extended form of X/P UTR RNA.
To determine the effect of DDX21 on X/P UTR structure, we
added GST-fused DDX21 to the RNA probe during the
equilibration period. When the X/P UTR probe was reacted
with the active DDX21, high mobility bands were observed in the
gels (Figure 8A and 8B, asterisks). On the other hand, the heat-
inactivated DDX21 failed to produce such bands (Figure 8A). The
major bands were restored even in the presence of proteins, when
the re-boiling process was conducted after the equilibration step
(Figure 8B, double-asterisks). These results suggested that DDX21
caused the folding of the UTR probe and produce the high
mobility bands in the gels. Therefore, DDX21 is likely to cause
structural alteration of the 59 UTR of the X/P mRNA.
BDV P interferes with the interaction of DDX21 and the
X/P UTR
To examine the effect of DDX21 on the translation of the X
ORF, we performed a coupled assay of in vitro RNA binding and in
vitro translation using in vitro transcribed X/P mRNA and
recombinant DDX21. As shown in Figure 9A, incubation with
Figure 4. Nuclear proteins suppress translation of the X ORF via the 59 UTR of the mRNA. (A) A nuclear extract inhibits the initiation of
translation of the X ORF. The extracts (1 mg) from OL cells were incubated with in vitro transcribed X- or P-Luciferase fusion RNA (X-Luc, P-Luc) in 20 ml
of binding buffer. After the reaction, in vitro translation was performed using a reticulocyte lysate mixture. After the incubation, 10 ml of the mixture
was subjected to luciferase assay. D59 UTR indicates luciferase plasmids lacking the 59 UTR of X/P mRNA. (B) The nuclear factors interact with the X/P
UTR. A serial amount of decoy RNA (X/P and M/G UTR) was incubated with the nuclear extract (4 mg) prior to incubation with X-Luc RNA, and then in
vitro translation was performed using the reticulocyte lysate mixture. Relative luciferase activities of the X fusion protein were determined. The mean
plus S.D. of three independent experiments are shown. **P,0.01, *P,0.05 (Student’s t test). (C and D) RNA EMSAs were performed using nuclear
extracts of OL cells as described in Methods. For competition, serial amounts of non-labeled own (C) or M/G UTR probes (D) were incubated with the
nuclear extract. Arrows indicate shifted bands produced by incubation with the nuclear extract. Bound complexes were resolved from free RNA by
electrophoresis in 4% native polyacrylamide gels.
doi:10.1371/journal.ppat.1000654.g004
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the X/P mRNA. This result suggested that DDX21 inhibits
ribosomal scanning through its binding to the X/P mRNA,
resulting in suppression of translation of both X and P. However,
the difficulty of the reaction conditions, which must be suitable for
in vitro RNA binding and in vitro translation reactions in the same
Figure 5. Identification of the 59 UTR-binding proteins. (A) Silver staining of sequential RNA column purified proteins is shown. The bands
specific for the X/P UTR probe (X/P) are indicated. M/G represents a control RNA column using the 59 UTR of M/G mRNA. (B) The specificity of
identified proteins was determined by Western blotting using antibodies specific to each protein (see Materials and Methods).
doi:10.1371/journal.ppat.1000654.g005
Figure 6. Interaction among the 59 UTR-binding proteins. (A and B) Interaction of endogenous DDX21 (A) and nucleolin (B) with Flag-tagged
UBPs. OL cells were transfected with 10 mg of each Flag-tagged UBP expression plasmid and lysates were immunoprecipitated with anti-FLAG
antibody. Western blot analysis was performed using anti-Flag and anti-DDX21 (A) or anti-nucleolin (B) antibodies. (C and D) Pull-down analyses of
Flag- and HA-tagged UBPs. OL cells were co-transfected with a combination of 5 mg each of the Flag-tagged and HA-tagged UBPs expression
plasmids indicated. At 36 h post-transfection, cell lysates were immunoprecipitated with anti-FLAG antibody. Western blot analysis was performed
using anti-HA antibody.
doi:10.1371/journal.ppat.1000654.g006
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ribosomal scanning may require its interaction with other UBPs,
suggested that this in vitro assay is insufficient to determine
completely the role of DDX21 in translation. Furthermore,
although we generated short-interfering RNAs for UBPs, includ-
ing DDX21, expression of the siRNAs appeared to induce
Figure 7. DDX21 is a core protein interacting with the 59 UTR of X/P mRNA. (A) Immunoprecipitation RT-PCR analysis of UBPs in BDV-
infected cells. BDV-infected OL cells were transfected with Flag-tagged UBP expression plasmids. Cell lysates were prepared with RIPA buffer
including ribonuclease inhibitor and immunoprecipitated with anti-Flag antibody. The co-purified RNAs in the immunoprecipitates were recovered in
TE buffer as described in the Methods section and RT-PCR analysis was performed using a specific primer set for X/P mRNA. (B) RNA EMSA was
performed by incubating
32P-labelled X/P UTR or M/G UTR riboprobe with GST-tagged DDX21 or nucleolin [Nuc (1234R)]. For competition, non-
labeled probes were incubated with each recombinant protein. Bound complexes were resolved from free RNA by electrophoresis in 4% native
polyacrylamide gels.
doi:10.1371/journal.ppat.1000654.g007
Figure 8. DDX21 causes structural alterations of X/P UTR. (A and B) In vitro RNA folding assays were performed with 1.0 pmol of
32P-labeled
X/P UTR riboprobe. The labeled riboprobe was incubated with 5 pmol of GST-tagged DDX21 and the folding reactions were detected as described in
the Methods section. After the incubation, the reaction mixtures were applied to a 12% native polyacrylamide gel. After electrophoresis, the gel was
exposed to X-ray film overnight at 280uC. Arrowheads indicate the X/P UTR riboprobe without boiling. Arrows and asterisks represent the extended
and folded RNAs on native gels, respectively. Double-asterisks in panel (B) indicate the migration of the riboprobes restored by the re-boiling of the
reaction mixture after incubation with DDX21.
doi:10.1371/journal.ppat.1000654.g008
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shown). Therefore, we sought to investigate further the effect of
DDX21 on the translation of the X ORF by focusing on its
interaction with P. P is phosphorylated and acts as a protein kinase
substrate, inhibiting the phosphorylation of host proteins to modify
their functions [39,40]. A recent study demonstrated the
phosphorylation of DDX21 [41]. Furthermore, the phosphoryla-
tion of RNA helicases, such as nucleolin, is known to be critical for
RNA-binding activity [42]. Therefore, it is tempting to speculate
that interference with phosphorylation by P affects the ability of
DDX21 to bind to the X/P UTR. To address this, we examined
whether the phosphorylation of DDX21 is affected by the
expression of P. OL cells were transfected with wt or mutant P,
P
S26/28A, in which two major phosphorylation sites (Ser26, Ser28)
were substituted by alanine [39,43], and the phosphorylation of
DDX21, as well as nucleolin, was monitored. Although the
Figure 9. Interaction between BDV P phosphorylation and translation of the X ORF. (A) In vitro RNA binding and translation assay of
DDX21 and X/P mRNA. In vitro transcribed X/P mRNA was incubated with recombinant DDX21 and then in vitro translation was performed using a
rabbit reticulocyte lysate, according to the manufacturer’s recommendations. After incubation, 10 ml of the mixture was subjected to SDS-PAGE and
Western blotting using anti-P and -X antibodies. (B) BDV P does not influence the expression of UBPs. OL cells were transfected with plasmids
expressing BDV N, P or P
S26/28A, and 48 h post-transfection the cells were lysed with sample buffer and then subjected to Western blotting using the
antibodies indicated. (C) Expression of P reduces phosphorylation levels of DDX21 and nucleolin. Flag-tagged DDX21 or nucleolin was cotransfected
with BDV N, P or P
S26/28A into OL cells. Forty-eight h after transfection, the cell lysates were immunoprecipitated by anti-Flag antibody and the
immunoprecipitants were detected by anti-Flag and anti-phosphoserine antibodies. (D) Expression of P reduces the RNA-binding activity of DDX21
and nucleolin. Flag-tagged recombinant DDX21 and nucleolin were obtained from lysates of OL cells transfected with either empty (E), wt P (P) or
mutant P (P
S26/28A) expression plasmid, and in vitro RNA binding assay was performed with
32P-labeled X/P UTR riboprobe and purified recombinant
proteins as described in the Methods section. Each value represents the mean plus S.D. of at least three independent experiments. **P,0.01,
(Student’s t test). (E) BDV P, but not the P
S26/28A mutant, enhances translation of X ORF. OL cells were cotransfected with 0.4 g of pX/PDP and a
serially diluted P or P
S26/28A plasmid (4 fold dilution; 0.00625, 0.025, 0.1, 0.4 mg). The expression of BDV X, P and P
S26/28A was detected by Western
blotting. The relative expression level of X is shown. Each value represents the mean plus S.D. of three independent experiments. E: empty plasmid-
transfected. **P,0.01, *P,0.05 (Student’s t test).
doi:10.1371/journal.ppat.1000654.g009
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P (Figure 9B), the phosphorylation levels of both DDX21 and
nucleolin decreased clearly in the cells transfected with wt P, but
not with P
S26/28A (Figure 9C).
To investigate whether the hypophosphorylation of DDX21 in the
presence of P modulates its RNA binding activity, we extracted Flag-
tagged DDX21 from the cells transfected with wt P or P
S26/28A and
then estimated its binding ability to the
32P-labelled X/P UTR probe
using an in vitro RNA binding assay. As shown in Figure 9D, Flag-
tagged DDX21, as well as nucleolin, from wt P-transfected cells
exhibited significant reduction of binding to X/P UTR. The binding
activities of the tagged proteins from the cells transfected with P
S26/28A
were significantly higher than those with wt P, suggesting that
interference with phosphorylation by P decreases the RNA binding
activity of DDX21. Therefore, we finally examined whether
phosphorylation of P directly affects translation of the X ORF.
Consistent with Figure 3B, the expression of X was significantly
upregulated in the pX/PDP-transfected cells in the presence of wt P in
a dose-dependent fashion, whereas the P
S26/28A mutant was not able
to upregulate the translation of X (Figure 9E). Altogether, these results
suggested that BDV P may inhibit the binding of DDX21 to the 59
UTR by interfering with its phosphorylation, resulting in the
upregulation of the ribosomal reinitiation from the X-AUG.
Discussion
In this study, we demonstrated translational regulation of
polycistronic mRNA in a unique animal RNA virus. The BDV
X/P polycistronic mRNA encodes three overlapping ORFs within
a short, 0.8 kb sequence. We showed that the X and P ORFs are
translated predominantly by a reinitiation strategy, following the
termination of translation of the uORF, although a leaky scanning
mechanism is implicated to some extent in the translational
processes. In this study, we employed an RNA polymerase
II-controlled vector for expression of the X/P mRNA in
transfected cells. We have carefully investigated the expression,
as well as the structure, of the transcripts from pX/P plasmid
DNAs in each experiment and then verified that our system could
recreate the translational regulation of X/P mRNA in BDV-
infected cells (data not shown). Currently, two types of reinitiation
mechanism have been identified in eukaryotic and viral mRNAs
[2,3,6,11,17,18]. The first type of mRNAs contain short uORFs
(,30 codons) upstream of the main ORFs. In this mechanism, the
efficiency of reinitiation is controlled by the length of the uORF
and by the intercistronic region, an appropriate distance being
necessary for the recharging of reinitiation factors, including eIF2
and Met-tRNAiMet, to the ribosomes. Cellular mRNAs such as
C/EBP and AdoMetDC, are representative examples of this type
of regulation [17,44]. In the X/P mRNA, initiation of translation
of the P ORF may be mediated by this type of reinitiation
mechanism. The scanning ribosomes, which travel continuously
on the mRNA after termination of translation of the uORF, must
recharge the initiation factors on the intercistronic region between
the uORF and P ORF and efficiently initiate translation from the
P-AUG. Note that the expression level of P is quite invariant, with
or without translation of X, if the uORF is present (Figure 2),
indicating that the number of ribosomes, which move continuously
along the mRNA after uORF termination, is relatively constant on
the X/P mRNA. This may be the mechanism underlying the
stable and persistent expression of P in infected cells.
The second type of reinitiation mechanism involves mRNAs
containing long 59 ORFs, which usually encode functional
proteins. These mRNAs display only short intercistronic distances
between the upstream and downstream ORFs, or even may
overlap. It has been shown that efficient reinitiation in this
mechanism is determined by the stability/mobility of ribosomal
complexes to allow reinitiation at the downstream initiation codon
[17,18]. Among viral mRNAs, segment 7 of influenza B virus [45],
the ORF-2 of the M2 gene of respiratory syncytial virus (RSV)
[46], and the 39 terminal ORF (VP2) of feline calicivirus (FCV)
[47,48] represent are examples of this type of reinitiation process.
Our experiments revealed that reinitiation of the X ORF may be
regulated by this type of mechanism, although the uORF encodes
only a short and, probably, non-functional peptide. Interestingly,
the uORF and X ORF feature an overlapping stop-start codon,
UGAUG, as found in other viral polycistronic mRNAs [47,49,50].
This feature indicates that the overlapping stop-start codon of the
X/P mRNA may play a key role in the regulation of translation of
the X ORF. Previous studies revealed that genes divided by such
an overlapping stop-start codon are expressed predominantly by
termination-coupled translation, in which translation of the
downstream ORF is initiated by ribosomes which have read the
uORF and stalled at the overlapping stop-start codon [48,51]. The
downstream extension of the termination signal of the uORF in
the X/P mRNA significantly reduced the expression of X,
suggesting that ribosomal reinitiation from the X-AUG is also
carried out by the coupled translation mechanism associated with
uORF termination.
The regulation of ribosomal movement/stability around the
overlapping stop-start codon must be crucial for controlling the
translation of the downstream ORF. The scanning ribosomes,
which have not dissociated from the mRNA after stalling at the
uORF termination codon, may be reutilized efficiently for the
reinitiation of translation of the X ORF. In favor of this
hypothesis, we found that host nuclear factors influence ribosomal
initiation of the X ORF through interaction with the 59 UTR and
identified RNA helicase complexes, mainly involving DDX21.
DDX21 is a DEAD-box RNA helicase that localizes to the
nucleoli and is involved in ribosomal RNA synthesis or processing
[38,52,53]. Although detailed functions of DDX21 have not been
elucidated yet, this helicase appears to fold or unwind RNA or
ribonucleoprotein structures through regulation of RNA-RNA or
RNA-protein interaction [38,52,53]. We found that DDX21 may
be a scaffold protein that interacts with the X/P UTR, among the
UBPs, and causes structural alteration of the 59 UTR. Numerous
reports have demonstrated that RNA secondary structure
contributes to translational control by affecting the constancy of
ribosomal scanning on mRNAs or the recognition of initiation
signals [6,54]. The ribosomes may stack or pass through the
initiation codons if secondary structures are formed around the
initiation site, leading to enhancement or reduction of the
translation efficiency of the ORFs. Therefore, it is conceivable
that structural modification of the X/P UTR by DDX21 and the
UBPs decreases the ribosomal reinitiation at the X ORF or
increases ribosomal dissociation from the mRNA after termination
of translation of the uORF, both resulting in the suppression of the
translation of the X ORF (Figure 10, left arrow). We found that
the structural alterations induced by the base-pair changes in a
short stem-loop structure within the X/P UTR influence the
translation of the X ORF (Figure S8), supporting this conclusion.
On the other hand, in this model the structural change of the X/P
UTR should occur in the cytoplasm. Considering DDX21 is
mostly a nuclear protein [53], it is possible that the transient
interaction of DDX21 with X/P mRNA in the nucleus is enough
to maintain the structure of X/P UTR in the cytoplasm by
introducing the UBPs (Figure 10, left arrow). Alternatively,
DDX21 may be transported to the cytoplasm along with the
mRNA in this case.
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nucleolin, is inhibited by expression of P. Previous studies
demonstrated that hyperphosphorylation of nucleolin increases
its RNA binding affinity, whereas dephosphorylation reduces the
affinity [42]. In this study, the RNA-binding activity of DDX21
was shown to be reduced significantly in cells expressing P. These
data suggested that accumulation of P in infected cells blocks
interaction of DDX21 with the X/P UTR, resulting in upregula-
tion of translation of the X ORF by promotion of ribosomal
reinitiation (Figure 10, right arrow). Note that in Figure 9D the
P
S26/28A did not fully recover the binding activity of DDX21 to the
X/P UTR. This suggests that hypophosphorylation of DDX21
may be not exclusively involved in the promotion of the translation
of X, although the in vitro binding assay based on the transfection
may be insensitive for the detection of the binding activity of
DDX21 to the 59 UTR.
Previous studies showed that the intranuclear stoichiometry of
N and P is important for BDV polymerase activity and that
accumulation of P in the nucleus markedly disturbs both viral
replication and persistent infection [21,55,56]. Interestingly, it has
been demonstrated that X binds directly to P and promotes
translocation of P to the cytoplasm from the nucleus [30,33].
Therefore, P-dependent translational regulation of X must be a
convenient and effective mechanism for ensuring an optimal level
of P in the nucleus. The nuclear accumulation of P above the
threshold level upregulates the translation of X, thereby leading to
the translocation of P to the cytoplasm. This could keep the
amount of P at the optimal level in the nucleus, which is
unequivocally necessary for productive replication and/or persis-
tent infection of BDV in the nucleus. A previous study, which
demonstrated that the mutations in Ser26 and Ser28 of P
aberrantly upregulate the viral polymerase complex activity, and
that recombinant BDVs containing the phosphorylation mutations
(rBDV-P
S26/28A) reduce the expression of X in infected cells [43],
may be consistent with our findings, although the possibility that
two amino acid changes inevitably introduced in the X ORF of
rBDV-P
S26/28A affect the expression level of X has remained. In
addition, a recent work using a mutant rBDV, which ectopically
expresses X under the different transcriptional unit, demonstrated
that the expression of X from the mutant virus is not as tightly
linked to expression of P as in the wild type BDV, resulting in
strong attenuation of the replication of the rBDV in rat brains
[57]. This observation may also support our conclusion that the
X/P UTR is not only specifically involved in the regulational
expression of X but also essentially controls the balanced
expression between X and P in infected cells. Furthermore, a
recent work by Poenisch et al. [31] showed that recombinant
BDVs containing either a premature stop codon in the uORF or
mutations ablating the stop codons of the uORF express wild-type
like X and P in cultured cells and efficiently replicate in the brains
of adult rats. Although this observation may seem to conflict with
our findings that the overlapped termination of uORF is critical
for the translation reinitiation of X, the recombinant viruses may
be able to recover the translation level of X by the expression of
other transcription unit, such as a 1.9-kb mRNA, resulting in the
efficient replication in infected cells. In fact, Poenisch et al. [31]
have demonstrated that the 1.9-kb mRNA not only serves as a
template for the synthesis of N but also might be used for the
translation of the viral P protein and possibly X, suggesting that
the 1.9-kb transcript is a multicistronic mRNA of BDV.
Figure 10. Possible mechanism of autogenous regulation of BDV polycistronic mRNA translation. During the early stage of BDV
replication, the phosphorylated DDX21 and other UBPs, including nucleolin, interact with the 59 UTR of X/P mRNA (left arrow). The interaction may
facilitate dissociation or impede X-AUG recognition of ribosomes at the overlapping stop-start codon, leading to inefficient termination-coupled
reinitiation, by ribosomes which have translated the uORF, at the X ORF. The DDX21 may be dissociated from the 59 UTR in the cytoplasm. BDV P
accumulation in BDV-infected cells may interfere with phosphorylation of DDX21 and UBPs (right arrow), resulting in the detachment of the RNA
helicase complex from the 59 UTR. The free 59 UTR may increase the reinitiation processes of ribosomes at X-AUG.
doi:10.1371/journal.ppat.1000654.g010
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translational regulation of polycistronic mRNA mediated by its
own encoding protein and host RNA helicases. The detailed
description of the mechanism should provide novel insights into
not only an ingenious strategy of virus replication but also the roles
of RNA helicases in the translation of eukaryotic mRNAs. Further
study remains to be done to discover cellular mRNAs using a
similar translation strategy.
Materials and Methods
Cell culture and virus
The COS-7 cell line was grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 5% heat-inactivated fetal
calf serum (FCS) at 37uC in a humidified atmosphere of 95% air
and 5% CO2. The OL cell line, derived from a human
oligodendroglioma, was grown in high-glucose (4.5%) DMEM
supplemented with 5% FCS. Cells were passaged every 3 days.
The BDV strain huP2br [32,58] was used for analyses in this
study.
Plasmids
Construction of the expression plasmids for BDV X/P mRNA,
N, P and P phosphorylation mutants has been described elsewhere
[29,30,32,33,39,43]. The mutant forms of the plasmids were
generated using PCR-based site-directed mutagenesis. To gener-
ate X/P-Luciferase hybrid mRNAs, a luciferase gene was fused in
frame with the X and P ORFs at the 148 nt and 149 nt positions
of the coding sequences, respectively, and introduced into the
pcDNA3 vector (Invitrogen) at the Kpn I-Not I sites. The first AUG
codon of Luc was replaced by AAG. For expression of DDX21,
DDX50, nucleolin, TOP1 and hnRNPQ1, corresponding cDNAs
were amplified by RT-PCR from OL cells and inserted into
pcXN2, pET32a or pET42a vectors (Novagen). Cells were
transfected with equimolar ratios of plasmid DNAs using
Lipofectamine
TM 2000 (Invitrogen) or FuGENE6 (Roche Applied
Science), according to the manufacturer’s instructions, and cellular
samples were collected at the desired times. The introduction of
the correct sequences for the wild type and its mutant were
confirmed by DNA sequencing and Western blotting analysis of
protein production.
To generate glutathione S-transferase (GST)-tagged DDX21
and nucleolin recombinant proteins used in the Escherichia coli
system, we cloned the amplified cDNAs into the pET42a vector
(Novagen). The vectors were transformed into BL21 (DE3)
(Novagen), and the expression of the GST-tagged proteins was
induced by the addition of 0.3 mM IPTG. The cell pellets were
resuspended in PBS(-) and then lysed by sonication. After
centrifugation, the supernatants were loaded on glutathione
sepharose 4B (Amersham Biosciences). Eluted proteins were
concentrated using Centricon spin columns (Millipore Corpora-
tion) and dialyzed against a 20 mM HEPES (pH 7.5)-100 mM
KCl buffer.
The His-tagged DDX21 was generated by the insertion of the
PCR-based DDX21 cDNA into PET32a vector (Novagen) and the
resultant plasmid was transformed into Rosetta-gami B(De3)pLysS
competent cells (Novagen). Purification of the recombinant
DDX21 using Ni-NTA agarose (QIAGEN) was performed
according to the manufacturer’s recommendations.
Luciferase reporter assay
COS-7 and OL cells cultured in 12-well plates were transfected
with plasmids expressing X/P-Luc hybrid mRNA. At 6 h post-
transfection, cells were lysed and subjected to luciferase assay
system (Promega Corporation), according to the manufacturer’s
recommendations. The relative levels of luciferase activity were
calculated for each fusion plasmid.
Western blot and immunoprecipitation analyses
For Western blotting, equal amounts of total lysate proteins of
COS-7 or OL cells transfected with expression plasmids were
subjected to SDS-PAGE and transferred onto polyvinylidene
difluoride membrane (Millipore Corporation). Antibodies used in
this study were as follows: anti-BDV P mouse monoclonal, anti-
BDV X rabbit polyclonal antibodies [30,33], mouse anti-Flag M2
(Sigma-Aldrich), mouse anti-HA 12CA5 (Roche Applied Science),
rabbit DDX21 (Bethyl Laboratories), rabbit Nucleolin (Novus
Biologicals), rabbit anti-Topo1 (TopGEN, Inc), mouse hnRNP-Q
(ImmunoQuest Ltd), rabbit anti-phosphoserine (ZYMED
Laboratories).
For immunoprecipitation (IP) assay, OL cells transfected with
Flag-tagged plasmids were lysed with RIPA buffer [20 mM Tris-
HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40
(NP-40), 1% Na-deoxycholate with protease inhibitors]. After
centrifugation at 15,000 rpm for 30 min, the supernatants were
incubated with 40 ml of pre-equilibrated anti-Flag M2 agarose
(Sigma-Aldrich) overnight at 4uC with gentle rotation. After
incubation, beads were collected by centrifugation at 6,000 rpm
for 40 s and washed four times with 1 ml of RIPA. The proteins
immunoprecipitated with anti-Flag agarose were eluted with
36Flag peptide (Sigma-Aldrich) in RIPA buffer and detected by
Western blotting as described above. In IP for detection of
phosphoserine, NaF and Na3VO4 were added in RIPA buffer,
and the serine-phosphorylated proteins were detected by anti-
phosphoserine antibody.
IP-RT-PCR
To detect the interaction of host factors with BDV X/P mRNA
in vivo, BDV-infected OL cells were transfected with Flag-tagged
targeted proteins and lysed with RIPA buffer with RNasin
(Promega). After IP with anti-Flag M2, the co-immunoprecipitants
were boiled in TE buffer and then treated with RNase-free DNase
I for 20 min. Total RNAs were isolated from the aqueous solution
and used as templates for RT-PCR using specific primers of X/P
mRNA.
In vitro translation assay
In vitro transcribed X/P-Luc mRNAs were prepared with
Maxiscript Kits (Ambion). About 1.0 pmol of X/P-Luc mRNAs
were pre-incubated with nuclear extracts of OL cells (total protein
1t o4mg) in a total 20 ml of binding mixture [10 mM HEPES
(pH 7.6), 67 mM NaCl, 2 mM MgCl2, 1 mM DTT, 1 mM
EDTA, 5% glycerol, 10U RNasin] for 30 min at room
temperature. For competition, a serial dilutions of decoy RNAs
were pre-incubated with the extracts prior to the reaction. Binding
mixtures were then subjected to the in vitro translation system using
50 ml of rabbit reticulocyte lysate (Promega), according to the
manufacturer’s recommendations. After incubation period of 2 h
at 30uC, 10 ml of mixture was subjected to luciferase assay as
described above.
RNA EMSA
The
32P labeled-transcripts corresponding to the X/P and M/G
UTRs were prepared with a mirVana miRNA Probe construction
kit (Ambion), using PCR products or synthetic oligonucleotides as
dsDNA templates. Transcription of the X/P and M/G UTRs was
confirmed by their mobility in native PAGE. Unlabeled transcripts
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TM T7 Kit (Ambion). The
cell extracts were obtained from exponentially growing OL cells.
The cells were lysed with buffer A [20 mM HEPES (pH 7.6),
10 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM DTT,
0.1% NP-40, 20% glycerol and protease inhibitor cocktail] and
then incubated on ice for 5 min. After collection of the cells, the
lysate was incubated for a further 10 min. After centrifugation at
2,000 rpm for 5 min, the supernatant was collected as the
cytoplasmic extract. The pellet was lysed with buffer B [20 mM
HEPES (pH 7.6), 500 mM NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, 1 mM DTT, 0.1% NP-40, 20% glycerol and protease
inhibitor cocktail], incubated on ice for 30 min and separated by
centrifugation at 15,000 rpm for 15 min. The soluble nuclear
fraction was diluted in binding buffer [10 mM HEPES (pH 7.6),
100 mM NaCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT,
0.1% NP-40, 10% glycerol]. About 1.0 pmol of
32P-labeled
gel-purified probes was incubated with the nuclear extracts (4 mg)
in a total of 30 ml of binding mixture [10 mM HEPES (pH 7.6),
67 mM NaCl, 2 mM MgCl2, 1 mM DTT, 1 mM EDTA, 5%
glycerol, 20 mg tRNA, 10 U RNasin] for 20 min at room
temperature. For competition, non-labeled probes were incubated
with the nuclear extract for 20 min at room temperature prior to
incubation with the labeled probes. For the assays using
recombinant proteins, the probes were incubated with 5 pmol of
GST-tagged DDX21 or nucleolin in a total of 20 ml of binding
mixture [20 mM HEPES (pH7.5), 70 mM KCl, 2 mM MgCl2,
2 mM DTT, 0.2 mg/ml BSA, 20 U RNasin] for 10 min at 30uC
and for 10 min at room temperature. The reaction mixtures were
applied to 4% native polyacrylamide gels (40:1 acrylamide-
bisacrylamide) in TBE buffer. After electrophoresis, the gels were
exposed to X-ray film overnight at 280uC.
RNA-affinity column purification of the 59 UTR-binding
proteins
Nuclear extracts of OL cells were prepared as described above.
The nuclear extracts were passed through the RNA-negative
coupled column and then loaded onto a consecutive RNA-positive
column to remove nonspecific binding proteins. The extracts (total
2.5 mg of protein) were loaded on HiTrap Streptavidin HP
column (1.0 ml bed volume; GE Healthcare) equilibrated with
binding buffer three times (0.2 ml/min). The flow-through was
incubated with 0.02 mmol of a 59-biotinylated short (20 mer) RNA
probe in binding buffer on ice for 30 min, and passed through a
HiTrap column three times (0.2 ml/min). The column was
washed with 30 ml binding buffer and then the proteins were
eluted from the columns by the addition of binding buffer
containing 600 mM NaCl. After dialysis with binding buffer, the
sample was subjected to an X/P UTR- or M/G UTR-coupled
column as a second step of RNA-affinity purification. After
washing, the binding proteins were eluted from the column with
the same as for the short RNA probe-coupled column.
LC-MS/MS
Samples eluted from the RNA affinity columns were separated
on 10% SDS-PAGE and visualized by silver-staining (Wako). The
protein bands of interest were excised, digested in-gel with trypsin,
and analyzed by nanocapillary reversed-phase LC-MS/MS using
a C18 column (Q 75 mm) on a nanoLC system (Ultimate, LC
Packing) coupled to a quadrupole time-of-flight mass spectrometer
(QTOF Ultima, Waters). Direct injection data-dependent acqui-
sition was performed using one MS channel for every three MS/
MS channels and dynamic exclusion for selected ions. Proteins
were identified by database searching using Mascot Server (Matrix
Science).
GST-pull down assay
For the protein pull-down assay, 200 pmol of recombinant His-
DDX21 and approximately 100 pmol of truncated forms of GST-
nucleolin were incubated with RIPA buffer for 1 h at 4uC. After
the incubation, reaction mixtures were bound to glutathione-
Sepharose 4B (Amersham Biosciences) in RIPA buffer overnight at
4uC. After washing with the same buffer three times, bound
proteins were analyzed by immunoblotting with anti-DDX21
antibodies.
In vitro RNA folding assay
About 1.0 pmol of
32P-labeled probes were heated at 85uC for
5 min, quickly cooled on ice and equilibrated at 23uC for 20 min
prior to the reaction, unless manipulated further. These RNAs
were incubated with 5 pmol of GST-tagged DDX21 and GST-
tagged truncated nucleolin, Nuc(1234R) in total 15 ml of binding
mixture [20mM HEPES (pH 7.5), 70 mM KCl, 3 mM ATP,
0.2 mg/ml BSA, 20 U RNasin] at 23uC for 20 min. After the
incubation, the reaction was terminated by the addition of
56loading buffer [20 mM HEPES (pH 7.5), 70 mM KCl, 50%
glycerol, 0.5% SDS, 0.2 mg/ml proteinase K, 0.01% BPB, 0.01%
XC], which also inactivated the enzyme. A part of the reaction
mixtures was then applied to 12% native polyacrylamide gel (40:1
acrylamide-bisacrylamide) in TBE buffer. After electrophoresis,
the gels were exposed to X-ray film overnight at 280uC.
In vitro RNA binding assay
The OL cells expressing Flag-tagged recombinant proteins were
lysed with RIPA buffer including protease inhibitors and 40 mg/ml
of RNase A, and IP were performed using anti-Flag M2 as
described above. The precipitants were washed twice with washing
buffer [20 mM Tris-HCl (pH 7.5), 70 mM NaCl, 70 mM KCl,
0.1% NP-40] and once with binding buffer [20 mM Tris-HCl
(pH 7.5), 70 mM KCl, 0.1% NP-40] and subjected to in vitro
binding assay. 10 pmol of
32P-labeled X/P UTR probe was added
to 20 ml of 50% suspension of the protein-loaded beads. After
adjusting the total volume to 250 ml with binding buffer, the
reaction mixture was incubated at 4uC for 10 min with gentle
agitation. Unbound probe was removed by washing three times
with 1 ml of binding buffer. The amount of bound radio-activity
was measured by scintillation counting and the specificity was
achieved by eliminating background activity obtained from the
bead with the mock-transfected cell extract.
Supporting Information
Figure S1 The translation of X is suppressed at an early stage of
BDV infection. BDV strain He80 was infected into C6 (rat glioma)
or OL (human oligodendroglioma) cells. The subcellular localiza-
tion of X and P was determined by immunofluorescence assay
using anti-BDV P and X antibodies. The cells were analyzed when
the infection rate was below 5% and reached 100% as early and
persistent stages, respectively.
Found at: doi:10.1371/journal.ppat.1000654.s001 (0.54 MB PDF)
Figure S2 The translation of uORF influences translation of the
X ORF. (A) Schematic representation of deletion mutants of the 59
UTR of X/P expression plasmid. The nucleotide regions deleted
from the wt plasmid are shown. The nucleotide region between 23
and 42 contains a short-stem loop structure shown in Figure S8.
(B) OL cells were transfected with 0.8 mg of each plasmid and at
12 h after transfection cells were harvested and subjected to
Western blotting using anti-BDV P and X antibodies. (C) Fold-
activation of X expression in the cells transfected with mutant
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ImageJ software.
Found at: doi:10.1371/journal.ppat.1000654.s002 (0.14 MB PDF)
Figure S3 Premature termination of uORF affects the expres-
sion of X. (A) Structure of uORF mutants. The nucleotide
sequences substituted from the wt plasmid are indicated. These
mutations do not induce structural modification of the 59 UTR of
X/P mRNA. (B) Expression of BDV P and X from the mutant
uORF expression plasmids. OL cells cultured in 12 well culture
dishes were transfected with 0.8 mg of wt and uORF mutant
plasmids. Twelve h post-transfection, cells were lysed and
subjected to western blot analysis using anti-BDV P and X
antibodies. (C) Relative expression of X and P in uORF mutant
plasmid-transfected OL cells. The band intensities shown in (B)
were determined after quantitation by ImageJ software. The
means plus S.D. of three independent experiments are shown.
**P,0.01, (Student’s t test).
Found at: doi:10.1371/journal.ppat.1000654.s003 (0.17 MB PDF)
Figure S4 Additional 59 or Kozak’s stem-loop structures in the
59 UTR inhibit translation initiation of X and P. (A and B)
Expression of BDV P and X from the 59 UTR mutant plasmids.
Schematic structure of 59 UTR mutants is shown. The 59-stem
and Kozak-stem were introduced upstream of the uAUG and by
replacing with uORF coding sequence, respectively. OL cells
cultured in 12-well culture dishes were transfected with 0.8 mgo f
each plasmid. Forty-eight h post-transfection, cells were lysed and
subjected to western blot analysis using anti-BDV P and X
antibodies. (C) Nucleotide sequences of artificial stem structures.
Found at: doi:10.1371/journal.ppat.1000654.s004 (0.17 MB PDF)
Figure S5 The predicted peptide of uORF does not influence
translation of X ORF. (A) Structure of a uORF mutant. The
nucleotide and amino acid sequences substituted from the wt
plasmid are indicated by black squares. These mutations do not
induce structural modification of the 59 UTR of X/P mRNA. 1
(wt): wild-type uORF, 2: mutant uORF. (B) Expression of BDV P
and X from the mutant uORF expression plasmid. OL cells
cultured in 12-well culture dishes were transfected with 0.8 mgo f
wt and uORF mutant plasmids. Forty-eight h post-transfection,
cells were lysed and subjected to western blot analysis using anti-
BDV P and X antibodies. (C) Relative expression of X and P in
uORF mutant plasmid-transfected OL cells. The band intensities
shown in (B) were determined after quantitation by ImageJ
software. The means plus S.D. of three independent experiments
are shown.
Found at: doi:10.1371/journal.ppat.1000654.s005 (0.12 MB PDF)
Figure S6 BDV P does not affect the functions of eukaryotic
initiation factors. (A) OL cells were transfected with Flag-tagged
BDV N or P plasmid and, forty-eight h post-transfection, cells
were lysed with RIPA or TNE buffer and then immunoprecip-
itated with Flag-M2 affinity gel. Immunoprecipitates were
analyzed using the indicated antibodies. CE indicates cell extract.
(B) Expression and phosphorylation of eIFs in BDV P-expressed
cells. The cells expressing BDV N or P were analyzed by western
blotting using the antibodies indicated. The phosphorylation of
eIF2a was detected by phosphoserine 51-eIF2a antibody.
Found at: doi:10.1371/journal.ppat.1000654.s006 (0.26 MB PDF)
Figure S7 GST-pull down assay of recombinant nucleolin. (A)
Schematic representation of truncation mutants of recombinant
GST-fused nucleolin. (B) In vitro pull-down assay between His-
tagged DDX21 and GST-fused recombinant nucleolins. 200 pmol
of recombinant His-DDX21 and approximately 100 pmol of
truncated GST-fused nucleolins were incubated with RIPA buffer
for 1 h at 4uC. Proteins precipitated with glutathione-Sepharose
beads were immunoblotted with anti-DDX21 antibody. Coomas-
sie brilliant blue (CBB) staining of His-tagged DDX21 and GST-
fused nucleolins at the top, which were bacterially expressed,
purified, and used for in vitro binding.
Found at: doi:10.1371/journal.ppat.1000654.s007 (0.14 MB PDF)
Figure S8 The stability of the 59 UTR controls translation of X
ORF. (A) Schematic representation of a short stem-loop (SL)
structure in the 59 UTR. (B) Base-pair changing mutations were
introduced within the SL region. The nucleotide substitutions are
indicated by black squares. OL cells were transfected with 0.8 mg
of wt and SL mutants, and at 48 h post-transfection, cells were
subjected to western blotting using anti-BDV P mouse monoclonal
and anti-BDV X rabbit polyclonal antibodies. Predicted free
energies (kcal/mol) of SL structures are shown. (C) Relative
expression of X and P was determined after quantitation of band
intensities by ImageJ software. The mean plus S.D. of three
independent experiments are shown.
Found at: doi:10.1371/journal.ppat.1000654.s008 (0.12 MB PDF)
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